The Wall Street Transcript
The Wall Street Transcript - In-Depth Interviews for Investors

Wall Street Transcript Products

Total Online Access

Complete Access to New Interviews, the Archive, and all Special Reports.

✓ Subscriber Hotline – Instant access to new exclusive interviews and content
✓ Money Manager – Interviews with expert portfolio management executives
✓ Equity Analyst – Interviews from leading investments banks
✓ Roundtable Transcripts – With Equity Analyst and Money Manager experts
✓ Archive – Over 14,000 interviews and editorial content items published online from 1998
✓ Special Conference Editions – Special Annual Reviews and Industry Focus Reports
Full Year
$1995 Quarter
$495

Investing Strategies

Money Manager Interviews:
✓ Access to entire database of leading buy side portfolio management interviews since 1998
✓ 15 to 25 new interviews each month
✓ Niche investment sectors and all strategy types
✓ Roundtable discussions between leading asset managers
Full Year
$390 Quarter
$175

Industry Sectors

The Sector Focus subscription permits industry specific access.
Technology
Full Year
$390 Quarter
$175
Healthcare
Full Year
$390 Quarter
$175
Natural Resources
Full Year
$390 Quarter
$175
Industry & Services
Full Year
$390 Quarter
$175
Consumer
Full Year
$390 Quarter
$175
Financial Services
Full Year
$390 Quarter
$175

Industry Sector Reports $175

Collection of timely interviews for different industries. Most recent reports:

Single Interviews

Most popular recent articles:

Investing Strategies

Published March 22, 2019

Buy ($175)

Proprietary Genome Editing Platforms

Published March 22, 2019

Buy ($175)
 

Buying Competitively Advantaged Companies in the Midcap Space

Published March 22, 2019 in Investing Strategies

Buy ($25)

Looking for Stocks That Both Pay and Grow Dividends

Published March 22, 2019 in Investing Strategies

Companies covered:

NYSE:BA OTCMKTS:EADSY NASDAQ:AVGO NASDAQ:ADI NYSE:RCL NASDAQ:GOOG Buy ($25)

Investing Long Term in the Best-Positioned Companies

Published March 22, 2019 in Investing Strategies

Buy ($25)

Producing Above-Average Results with a Contrarian Strategy

Published March 22, 2019 in Investing Strategies

Companies covered:

NYSE:JPM NYSE:WFC NYSE:XOM NASDAQ:FB NYSE:PSX NYSE:COP NYSE:TD NYSE:GE NYSE:BA Buy ($25)

Interview with the CEO: NeuBase Therapeutics, Inc. (NASDAQ:NBSE)

Published March 22, 2019 in Proprietary Genome Editing Platforms

Companies covered:

NASDAQ:NBSE Buy ($25)

Interview with the President, CEO and CFO: Bio-Path Holdings, Inc. (NASDAQ:BPTH)

Published March 22, 2019 in Proprietary Genome Editing Platforms

Companies covered:

NASDAQ:BPTH Buy ($25)


Top Company Interviews

Microsoft Corporation
Intel Corporation
Pfizer, Inc.
General Electric Company
Wal-Mart Stores, Inc.
International Business Machines Corporation
Citigroup Inc.
Bank of America Corporation
Dell Inc.
Exxon Mobil Corporation
Verizon Communications Inc.
AT&T Inc.
CEO INTERVIEWS
Interview with the CEO: NeuBase Therapeutics, Inc. (NASDAQ:NBSE)
Interview with the President, CEO and CFO: Bio-Path Holdings, Inc. (NASDAQ:BPTH)
Interview with the President and CEO: Arcturus Therapeutics Ltd. (NASDAQ:ARCT)
SECTOR ROUNDTABLES
Natural Gas Weighs Heavy On E&P Near-Term Prospects
Roundtable Forum:optimism Despite Uncertainty In For-profit Education
Roundtable Forum:a Shift In Focus To Natural Gas From Oil
MONEY MANAGER INTERVIEWS
Buying Competitively Advantaged Companies in the Midcap Space
Looking for Stocks That Both Pay and Grow Dividends
Investing Long Term in the Best-Positioned Companies
ANALYST INTERVIEWS
A Big Year Ahead for Gene and Cell Therapy Companies
Major Pharmas Becoming Increasingly Comfortable with Gene Therapy
Clinical Data and M&A Serve as Catalysts in 2019
Since 1963
© The Wall Street Transcript 1997-2016
Terms and Conditions
Privacy Policy